Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
Descriptive epidemiology of age at HPV vaccination: Analysis using the 2020 NIS-Teen.
复制标题
DOI：
10.1080/21645515.2023.2204784
复制
发表时间：
2023-12-31
影响因子：
4.8
通讯作者：
中科院分区：
文献类型：
--
作者：
在美国，人乳头瘤病毒（HPV）疫苗接种率仍然不理想，并继续落后于破伤风、白喉和无细胞百日咳（Tdap）疫苗接种和四价脑膜炎球菌结合疫苗（MCV 4）。尽管这三种疫苗都被推荐在2005-2006年期间用于常规青少年使用。改善HPV疫苗接种的一个策略是在第一次机会开始疫苗系列-目前最小的年龄为9岁。关于HPV疫苗接种年龄的流行病学以及9-10岁接种疫苗的频率知之甚少。使用2020年国家免疫调查-青少年（NIS-Teen）数据，我们分析了HPV疫苗启动时的年龄以及相对于启动时年龄完成HPV疫苗系列的启动者比例。总体而言，4.0%的美国青少年在9-10岁时开始接种HPV疫苗，年轻出生队列的启动率（13岁为4.8%，14岁为5.1%）高于年龄较大的队列（16岁和17岁均为3.1%）。年龄组在3-4年后最大限度地完成HPV疫苗接种。在9-10岁开始的人中，93%的13岁儿童完成了这一系列。在11-12岁开始的学生中，完成率从13岁的66%上升到16岁的90.2%。在13-14岁开始学习的学生中，完成率从15岁的61%上升到17岁的84.9%。这份手稿作为一个比较的起点，为未来的流行病学评价HPV疫苗接种在第一时间。
Human papillomavirus (HPV) vaccination uptake in the United States remains suboptimal, and continues to trail that of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and quadrivalent meningococcal conjugate vaccination (MCV4). This is despite these three vaccines all being recommended for routine adolescent use within the 2005–2006 time period. One strategy to improve HPV vaccination is starting the vaccine series at the first opportunity – currently as young as 9 years of age. Little is known about the epidemiology of age at HPV vaccination, and the frequency of vaccination occurring at 9–10 years of age. Using 2020 National Immunization Survey-Teen (NIS-Teen) data, we analyzed age at HPV vaccine initiation and proportion of initiators completing the HPV vaccine series relative to age at initiation. Overall, 4.0% of US adolescents initiated HPV vaccination at 9–10 years of age, with higher initiation among younger birth cohorts (4.8% for 13-year-olds and 5.1% for 14-year-olds) than older cohorts (3.1% for both 16 and 17 year-olds). Age cohorts maximized HPV vaccine completion after 3–4 years. Among those initiating at ages 9–10, 93% of 13-year-olds completed the series. Among those initiating at 11–12, completion rates rose from 66% among 13-year-olds to 90.2% among 16-year-olds. Among those initiating at age 13–14, completion rose from 61% among 15-year-olds to 84.9% among 17-year-olds. This manuscript serves as a starting point of comparison for future epidemiologic evaluations of HPV vaccination at the first opportunity.
登录
查看更多内容
影响因子：
3.7
作者：
Casey, Sharon M.;Jansen, Emily;Perkins, Rebecca B.
通讯作者：
Perkins, Rebecca B.
DOI：
10.15585/mmwr.mm6429a3
发表时间：
2015-07-31
期刊：
MMWR. Morbidity and mortality weekly report
影响因子：
--
作者：
Reagan-Steiner S;Yankey D;Jeyarajah J;Elam-Evans LD;Singleton JA;Curtis CR;MacNeil J;Markowitz LE;Stokley S
通讯作者：
Stokley S
影响因子：
33.9
作者：
Reagan-Steiner, Sarah;Yankey, David;Singleton, James A.
通讯作者：
Singleton, James A.
影响因子：
3.1
作者：
Goleman, Martha J.;Dolce, Millie;Morack, Jennifer
通讯作者：
Morack, Jennifer
影响因子：
5.5
作者：
Healy, C. Mary;Montesinos, Diana P.;Middleman, Amy B.
通讯作者：
Middleman, Amy B.